Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Join SI Premium – FREE
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.13), $0.08 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
